September 2, 2020. By Jane Mundy.
West Palm Beach, FL Injectafer, an intravenous iron replacement drug, has recently caught the attention of researchers and the medical community, and in their wake, the legal community. Increasingly, researchers found that the benefits of Injectafer can be outweighed by the serious side effect of severely low phosphorus levels known as hypophosphatemia (HPP). Attorney Brenda Fulmer explains why this drug is still on the market and why patients are filing Injectafer lawsuits.
Read [
“Now is not the time to tinker with Injectafer labeling,” says Attorney ]
